| Product |
CAS |
Molecular formula |
More |
| 2-Methyl-4-(piperazin-1-yl)-6-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydron |
1378364-60-3 |
C23H32N4 |
More |
| 1-(4-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)pyridin-2- |
1378364-01-2 |
C24H33N3 |
More |
| 1-(5-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)pyridin-3- |
1312464-24-6 |
C24H33N3 |
More |
| 1-(2-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)pyridin-4- |
1378363-75-7 |
C24H33N3 |
More |
| 1-(6-(5,5,8,8-Tetramethyl-5,6,7,8-tetrahydronaphthalen-2-yl)pyrimidin- |
1378365-93-5 |
C23H32N4 |
More |
| 2-(4-(1H-imidazol-2-yl)piperidin-1-yl)-4-(3-(tert-butyl)-4-isopropoxyp |
1378365-55-9 |
C25H33N5O |
More |
| Tert-butyl 4-(6-(3-(tert-butyl)-4-isopropoxyphenyl)pyridin-2-yl)pipera |
1378367-31-7 |
C27H39N3O3 |
More |
| Tert-butyl 4-(4-(4-isopropoxy-3-isopropylphenyl)pyrimidin-2-yl)piperaz |
1378367-48-6 |
C25H36N4O3 |
More |
| Tert-butyl 4-(4-(4-isopropoxy-3-isopropylphenyl)-1,3,5-triazin-2-yl)pi |
1378367-86-2 |
C24H35N5O3 |
More |
| 2-(Tert-butyl)-n-cyclopentyl-4-(4-(piperazin-1-yl)pyrimidin-2-yl)anili |
1378366-61-0 |
C23H33N5 |
More |
| 1-(6-(2-(Benzyloxy)-1,1,3,3-tetramethyl-2,3-dihydro-1h-inden-5-yl)pyri |
1378366-14-3 |
C30H37N3O |
More |
| Tert-butyl 4-(6-(3-(cyclopentyloxy)-4-isopropylphenyl)pyridin-2-yl)pip |
1378367-66-8 |
C28H39N3O3 |
More |
| 1-(6-(3,4-Diisopropylphenyl)pyridin-2-yl)piperazine |
1378366-32-5 |
C21H29N3 |
More |
| 1-(6-(3,4-Diisopropylphenyl)pyridin-2-yl)piperazine dihydrochloride |
1378365-02-6 |
C21H29N3.2HCL |
More |
| 4-(4-Isopropoxy-3-isopropylphenyl)-2-(piperazin-1-yl)pyrimidine dihydr |
1378364-87-4 |
C20H28N4O.2HCL |
More |
| Cyclopropylsulfonylamine tert-butyl carbamate |
681808-26-4 |
C8H15NO4S |
More |
| [[(1,1-Dimethylethoxy)carbonyl]phenylamino]acetic acid |
150806-61-4 |
C13H17NO4 |
More |
| 2-(4-Isopropyl-1,3-thiazol-2-yl)-7-methoxyquinolin-4-ol |
300831-08-7 |
C16H16N2O2S |
More |
| 4-Isopropyl-1,3-thiazole |
17626-74-3 |
C6H9NS |
More |
| 2-Bromo-1-cyclobutyl-1-ethanone |
128312-69-6 |
C6H9BrO |
More |